Skip to main content
logo
OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.570
+0.110 (7.53%)
Aug 20, 2026, 4:00 PM EDT - Market closed

OS Therapies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
704991---
Market Cap Growth
0.58%-45.77%----
Enterprise Value
704889---
Last Close Price
1.461.404.28---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-7.77----
PB Ratio
--9.81112.02---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
----0.61-0.59-0.62
Net Debt / Equity Ratio
0.020.05-6.82-0.61-0.58-0.61
Net Debt / EBITDA Ratio
0.010.010.81-3.36-2.29-1.45
Net Debt / FCF Ratio
0.010.020.76-4.85-2.68-1.58
Quick Ratio
0.160.021.200.000.030.02
Current Ratio
0.180.031.200.030.080.09
Return on Assets (ROA)
-232.65%-289.88%-134.41%-415.27%-665.62%-301.75%
Return on Capital Employed (ROCE)
350.10%582.90%-747.60%18.20%78.90%152.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-59.33%-58.32%-9.77%---
FCF Yield
-27.93%-28.88%-8.01%---
Buyback Yield / Dilution
-125.88%-320.90%-28.01%45.60%--18.50%
SEC Filings: 10-K · 10-Q